apollo
0
Written By Santoshini Reddy G , M Pharmacy
Reviewed By Dr Aneela Siddabathuni , MPharma., PhD
Last Updated Dec 7, 2024 | 2:17 PM IST

Ganivian PFS 0.25 mg Injection is used to treat infertility in women. It is also indicated for the inhibition of premature luteinising hormone (LH) surges in women undergoing controlled ovarian hyperstimulation. It contains Ganirelix, which works by inhibiting the action of gonadotropin-releasing hormone (GnRH), resulting in the suppression of the LH. It prevents women from ovulating (release of the egg from the ovary) too soon during the stimulation of their ovaries to produce a mature egg.

Read more
Prescription drug

Whats That

tooltip
Prescription drug
 Trailing icon
Consult Doctor

Composition

GANIRELIX-0.25MG

Manufacturer/Marketer

Nivian Pharma Llp

Consume Type

PARENTERAL

Return Policy

Not Returnable

Expires on or after

Jan-27

for this medicine

About Ganivian PFS 0.25 mg Injection

Ganivian PFS 0.25 mg Injection belongs to the group of medicines called antigonadotropin-releasing hormones used to treat infertility in women. It is indicated for the inhibition of premature luteinising hormone (LH) surges in women undergoing controlled ovarian hyperstimulation.

Ganivian PFS 0.25 mg Injection contains Ganirelix, which works by inhibiting the action of gonadotropin-releasing hormone (GnRH), resulting in the suppression of the LH. It prevents women from ovulating too soon during the stimulation of their ovaries to produce a mature egg.

In some cases, Ganivian PFS 0.25 mg Injection may cause side effects such as injection site reactions, nausea, and headache. Most of these side effects may not require medical attention and resolve gradually over time. However, you are advised to talk to the doctor if the side effects persist or worsen.

Let the doctor know if you are allergic to any components in Ganivian PFS 0.25 mg Injection . Do not use Ganivian PFS 0.25 mg Injection if you are pregnant or breastfeeding. There is no relevant use of Ganivian PFS 0.25 mg Injection in children. Keep your doctor informed about your health condition and medicines to rule out any side effects.

Uses of Ganivian PFS 0.25 mg Injection

Treatment of Female infertility

Medicinal Benefits

Ganivian PFS 0.25 mg Injection belongs to the group of medicines called antigonadotropin-releasing hormones used to treat infertility in women. It is indicated for the inhibition of premature luteinising hormone (LH) surges in women undergoing controlled ovarian hyperstimulation. Ganivian PFS 0.25 mg Injection contains Ganirelix, which works by inhibiting the action of gonadotropin-releasing hormone (GnRH), resulting in the suppression of the LH. It prevents women from ovulating (release of the egg from the ovary) too soon during the stimulation of their ovaries to produce a mature egg.

Directions for Use

Use Ganivian PFS 0.25 mg Injection exactly as advised by the doctor. Ganivian PFS 0.25 mg Injection should be administered subcutaneously (under the skin), like the stomach or thigh. Wash your hands thoroughly with soap and water. Swab the injection site with a disinfectant to remove any surface bacteria. Pinch a fold of skin with the index finger and thumb. Insert the needle at the base of the pinched-up skin at an angle of 45° to the skin surface. Once the needle has been correctly placed, push the plunger down slowly and steadily so the solution is correctly injected and the skin tissues are not damaged. Push the plunger down until the syringe is empty, and wait for 5 seconds. Vary the injection site with each injection.

Storage

Store in a cool and dry place away from sunlight

Side Effects of Ganivian PFS 0.25 mg Injection

  • Nausea
  • Headache
  • Injection site reactions (redness, with or without swelling)

Drug Warnings

Do not use Ganivian PFS 0.25 mg Injection if you are allergic to any of its components, if you are hypersensitive to gonadotropin-releasing hormone (GnRH) or a GnRH analogue, if you have a moderate or severe kidney or liver disease, or if you are pregnant or breastfeeding. During or following hormonal stimulation of the ovaries, ovarian hyperstimulation syndrome may develop. There may be a slightly increased risk of an ectopic pregnancy (pregnancy outside of the uterus) in women with damaged fallopian tubes. Inform the doctor if you weigh below 50 kg or above 90 kg. Let the doctor know if you are taking any other medicines, including vitamin/mineral supplements or herbal products.

Drug Interactions

Drug-Drug Interactions: No interactions found/established.

Drug-Food Interactions: No interactions found/established.

Drug-Disease Interactions: No interactions found/established.

Habit Forming

No

Diet & Lifestyle Advise

  • Include healthy fruits and vegetables in your diet.
  • Avoid smoking and alcohol consumption.
  • Try relaxation therapy. Read a book or listen to soothing music.
  • Exercise moderately.
  • Do yoga or meditation, as it helps relieve stress.

Special Advise

  • You may need to have a negative pregnancy test before starting the treatment. 
  • Tell your doctor immediately if you become pregnant during therapy.

Disease/Condition Glossary

Female infertility: It is a condition in which a woman cannot become pregnant even after trying for at least one year or six months if the woman is over 35 years old. Age, hormonal problems, physical problems, lifestyle or environmental factors could be the causes of infertility.

bannner image

Alcohol

Consult your doctor

It is not known if alcohol affects Ganivian PFS 0.25 mg Injection . Please consult your doctor.

bannner image

Pregnancy

Unsafe

Do not use Ganivian PFS 0.25 mg Injection if you are pregnant, as it may cause birth defects.

bannner image

Breast Feeding

Unsafe

Do not use Ganivian PFS 0.25 mg Injection if you are breastfeeding.

bannner image

Driving

Consult your doctor

The effect of Ganivian PFS 0.25 mg Injection on the ability to drive has not been studied. Drive or operate machinery only if you are alert.

bannner image

Liver

Caution

Ganivian PFS 0.25 mg Injection is not recommended for use if you have moderate or severe liver disease. Please consult the doctor if you have a liver impairment or any concerns regarding this.

bannner image

Kidney

Caution

Ganivian PFS 0.25 mg Injection is not recommended for use if you have moderate or severe kidney disease. Please consult the doctor if you have kidney impairment or any concerns regarding this.

bannner image

Children

Consult your doctor

There is no relevant use of Ganivian PFS 0.25 mg Injection in children or adolescents.

Country of origin

India

Manufacturer/Marketer address

302, Lotus Plaza, Corner Of Gokhle Road And M.G. Road, Village, Naupada, Thane, Maharashtra 400062
Other Info - GAN0070

Author Details

Doctor imageWe provide you with authentic, trustworthy and relevant information

FAQs

Ganivian PFS 0.25 mg Injection is used to treat Female infertility.
Ganivian PFS 0.25 mg Injection prevents women from ovulating too soon during the stimulation of their ovaries to produce a mature egg.
Do not stop using Ganivian PFS 0.25 mg Injection unless advised by the doctor, as this may affect the outcome of your treatment. Talk to the doctor if you have any concerns.
Ganivian PFS 0.25 mg Injection may cause local injection site reactions like redness, with or without swelling. The local reaction usually disappears within 4 hours of administration. Vary the injection site with each injection.
Ganivian PFS 0.25 mg Injection works by inhibiting the action of gonadotropin-releasing hormone (GnRH), resulting in the suppression of the LH. It prevents women from ovulating too soon during the stimulation of their ovaries to produce a mature egg.
The common side effects of Ganivian PFS 0.25 mg Injection may include injection site reactions, nausea, and headache. Most of these side effects may not require medical attention and resolve gradually over time. However, you are advised to talk to the doctor if the side effects persist or worsen.

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.